Journal article
Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates
Abstract
The objective of this study was to compare the disintegration times among Canadian-marketed brand (alendronate 70 mg, alendronate 70 mg plus vitamin D 5600 IU, and risedronate 35 mg) and generic (Novo-alendronate 70 mg and Apo-alendronate 70 mg) once-weekly dosed bisphosphonates. All disintegration tests were performed with a Vanderkamp Disintegration Tester. Disintegration was deemed to have occurred when no residue of the tablet, except …
Authors
Olszynski WP; Adachi JD; Davison KS
Journal
Journal of Osteoporosis, Vol. 2014, No. 1,
Publisher
Hindawi
Publication Date
2014
DOI
10.1155/2014/420451
ISSN
2090-8059